Gritstone bio Takes Action to Preserve Value and Strengthen Capital Structure
Gritstone bio, Inc. (NASDAQ: GRTS) was downgraded by analysts at B. Riley from a "strong-buy" rating to a "hold" rating.
Gritstone bio, Inc. (NASDAQ: GRTS) was upgraded by analysts at Evercore ISI to a "strong-buy" rating.
Gritstone bio, Inc. (NASDAQ: GRTS) had its "neutral" rating re-affirmed by analysts at B. Riley. They now have a $1.00 price target on the stock, down previously from $3.00.
Gritstone bio, Inc. (NASDAQ: GRTS) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $0.50 price target on the stock, down previously from $4.00.